Radiopharmaceutical Therapy Breakthroughs Unveiled

New research highlights growing potential of radiopharmaceutical therapies to improve cancer outcomes

Published on Feb. 20, 2026

The inaugural Multidisciplinary Radiopharmaceutical Therapy Symposium, sponsored by the American Society for Radiation Oncology (ASTRO), is taking place in Palm Desert, California and online. The symposium features new research on established and emerging uses of radiopharmaceutical therapies (RPT) to treat cancer, as well as discussions on what clinics need to safely offer these treatments as they become more widely adopted.

Why it matters

Radiopharmaceutical therapies represent a promising new frontier in cancer treatment, with the potential to improve outcomes for patients. As these therapies move towards mainstream adoption, understanding the latest research and best practices for implementation will be crucial for oncology clinics and hospitals.

The details

The symposium covers a range of topics related to RPT, including established uses and early signals for new indications. Researchers will present findings from studies examining how RPT can be leveraged to treat various types of cancer. Discussions will also address the operational and safety considerations that clinics must have in place to offer these specialized treatments to patients.

  • The inaugural Multidisciplinary Radiopharmaceutical Therapy Symposium is taking place from February 17-19, 2026.

The players

American Society for Radiation Oncology (ASTRO)

A professional organization dedicated to advancing the practice of radiation oncology through education, research, and technological innovation.

Got photos? Submit your photos here. ›

The takeaway

As radiopharmaceutical therapies continue to demonstrate their potential to improve cancer treatment, this symposium provides a valuable platform for oncology professionals to share the latest research and best practices for implementing these specialized treatments in clinical settings.